Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Cash Position: Cash, cash equivalents, and marketable securities were $463.3 million as of September 30, 2024, compared to $322.0 million as of December 31, 2023. Erasca expects its current cash, cash ...

Net loss: Net loss was $7.1 million, or $0.15 per basic and diluted common share ... biopharmaceutical company developing ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting CD46, in combination with enzalutamide in patients with me ...

From exposure to the elements to inadequate nutrition, homeless seniors experience poor health outcomes in San Luis Obispo County.

The goal of the 2024 WTX Women Professional Women's Symposium was to bring women together to not only reflect on their journeys, but also to help broaden both their professional and communal spheres ...

"With our catalysts anticipated over the next 6 months in all of our core programs - including development of crofelemer for cancer therapy-related diarrhea, development of crofelemer for the ...